Biotech Values

[dewophile]

I went back to check the Merck vioxx case - settled for 4.85B with 60K outstanding suits. Here there are 70K suits, but spread out over several defendants. GSK lost about 5B in market cap
So far GSK has settled cases until last month when they won a verdict at trial. I think they will probably be motivated not to settle more and more while they appeal the Delaware ruling. Merck won about 2/3 of the cases before settling and was obviously the sole defendant unlike this case. So again an overshoot IMO by the market